# ğŸ‘‹ Hi, Iâ€™m Dr Binil Benny

ğŸ¯ **Pharmacometrician & QSP Scientist** | ğŸ§  Immuno-Oncology, CNS, Translational PKPD  
ğŸ“ Based in London | ğŸ§ª GitHub Portfolio | ğŸ”¬ 4+ yearsâ€™ experience in modeling, simulation, and regulatory pharmacology

---

## ğŸ’¼ What I Do
I specialize in:
- **Population PK/PD Modeling** (Monolix, NONMEM, R)
- **Quantitative Systems Pharmacology (QSP)** (SimBiology, PK-Sim,MoBi)
- **scRNA-seq Bioinformatics** (Seurat, UMAP, gene-level modeling)
- **Model-Informed Drug Development (MIDD)** strategy & reporting
- **Preclinical to Translational Simulation** (IVIVE, Winnonlin, PKAnalix, R, PyMol, Simulyx)

---

## ğŸ”¬ Featured Projects

| Project | Type | Description |
|--------|------|-------------|
| [Colistin_PopPK_Model](https://github.com/binilbenny1696/Colistin_PopPK_Model) | PopPK | ICU-based dosing simulation with Monolix |
| [CAR-T_QSP_Resistance_Model](https://github.com/binilbenny1696/CAR-T_QSP_Resistance_Model) | QSP + Omics | Tumor-kill + exhaustion + scRNA-seq integration |
| [DTP3_IVIVE_PKPD_Model](https://github.com/binilbenny1696/DTP3_IVIVE_PKPD_Model) | IVIVE | In vitro to in vivo simulation of myeloma compound |
| [AD_Cognitive_Decline_Simulation](https://github.com/binilbenny1696/AD_Cognitive_Decline_Simulation) | Disease Progression | Longitudinal Simulx trial simulation |
| [Liraglutide_QSP_Omics_Model](https://github.com/binilbenny1696/Liraglutide_QSP_Omics_Model) | Multi-Scale QSP | PKPD + structure + transcriptomics |
| [Risperidone_Depot_NCA](https://github.com/binilbenny1696/Risperidone_Depot_NCA) | Classic PK | LAI PK parameters from real patient data |

---

## ğŸŒ± Currently Exploring
- Bayesian pharmacometrics (brms, Stan)
- PBPK modeling in PK-Sim/MoBi
- Publishing projects to **ACoP / ISoP**

---

## ğŸ“¬ Reach Me
ğŸ“§ binilbenny76@gmail.com  
ğŸ”— [LinkedIn Profile](https://www.linkedin.com/in/bbenny7/)  
ğŸ—‚ï¸ [Project Board](https://standing-blinker-aaa.notion.site/1c2...) 

---

ğŸ“Œ *All project repos are published under MIT/CC licenses for educational use.*
